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Persistent hyperinsulinemic hypoglycemia of infancy:
long-term follow-up after surgical treatment
F.N. Wahid, M. Al Onazi, A. Al Rawaf, M. Al Muhaidly,
A. Al Otaibi and J. Al Hudhaif
Aim The aim of this study was to investigate the
long-term outcome of six children with persistent
hyperinsulinemic hypoglycemia of infancy (PHHI) after
pancreatectomy who have been followed since 1990 at the
Riyadh Military Hospital, Riyadh, Kingdom of Saudi Arabia.
Patients and methods Data from six patients were
retrospectively analyzed from chart review. PHHI was
diagnosed on the basis of having high-insulin levels and
low-glucose levels and a high insulin-to-glucose ratio.
Lactate, pyruvate, ammonia, and urinary organic acid levels
were recorded and tandem mass spectrometry screening
was performed. The patients were assessed radiologically
by MRI of the brain and by ultrasound examination of the
abdomen. Patients who failed medical therapy underwent
near-total pancreatectomy.
Results Hypoglycemic convulsion was the most common
presenting complaint. None of the patients responded to
medical treatment and thus underwent surgery.
Two patients still had hypoglycemic episodes after surgery,
requiring medical treatment. However, they underwent
subsequent surgery because of unresponsiveness to
medical therapy. Three patients developed diabetes.
None of them had malabsorption, and two patients
later developed epilepsy.
Conclusion The earlier the age at diagnosis, the better
the neurological outcome. Delayed surgery might be
associated with higher risk of development of diabetes.
Near-total (90–95%) pancreatectomy is the treatment
of choice for PHHI not responsive to medical
treatment. Ann Pediatr Surg 7:123–125 c 2011 Annals of
Pediatric Surgery.
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Introduction
Persistent hyperinsulinemic hypoglycemia of infancy
(PHHI), formally known as nesidioblastosis, is a glucose
metabolic disorder characterized by hypoglycemia and
inappropriate secretion of insulin [1]. The disease
includes focal and diffuse forms, both of which have a
similar clinical presentation. Its incidence in the general
population is one of 50 000 live births [2], but in areas
with high-consanguineous unions the incidence may be as
high as one of 2500 live births [3]. The familial form may
be caused by autosomal recessive or dominant defects in
the sulfonylurea receptor gene [4], the potassium inward-
rectifying receptor (Kir6.2) gene [5], the glutamate
dehydrogenase gene [6], or the glucokinase gene [7].
The chromosome involved is 11p14-15.1. Babies with
PHHI run a high risk of severe neurologic damage
secondary to severe hypoglycemia unless immediate and
adequate steps are taken [8]. These steps should include
high-glucose infusion and medical treatment with diaz-
oxide, octreotide (somatostatin analog), and nifedipine.
However, surgery should be considered if medical
treatment is not successful [9].
Patients and methods
We have retrospectively analyzed the charts of six
children at Riyadh Military Hospital, Riyadh. They were
diagnosed with PHHI in 1990. Four children (three girls
and one boy) belonged to the familial group and two were
in the sporadic group. The disease was diagnosed on the
basis of high-insulin levels, low-glucose levels, and a high
insulin-to-glucose ratio. All patients underwent assess-
ment of lactate, pyruvate, and ammonia levels, as well as
growth hormone, cortisol, and thyroid hormones. Urinary
organic acid screening and tandem mass spectrometry
were also performed. Radiological assessment was made
by MRI of the brain and by ultrasound examination of the
abdomen. Our management policy was to maintain blood
sugar level at more than 70 mg/dl (3.88 mmol/l). Medical
therapy included diazoxide (maximum dose: 25 mg/kg/
day) and octreotide (maximum dose: 40 mg/kg/day),
glucagon injection (as required) and intravenous glucose
infusion (15 mg/kg/min). If medical therapy as initial
management failed (lack of response), the patient was
subjected to near-total (90–95%) pancreatectomy. Sur-
gery was performed by an open technique. Blood sugar
was monitored frequently postoperatively. If the patient
remained hypoglycemic (blood glucose < 2 mmol/l), med-
ical therapy was started. Glucose infusion was continued
and adjusted according to blood sugar levels.
Results
All babies were born after full-term pregnancies. The
birth weights ranged from 3.3 to 3.8 kg (median: 3.6 kg).
There were six patients (four girls and two boys).
One family had four affected children. At the time
of this study, patient age ranged from 6 months to
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17 years (median age: 8 years). Age at diagnosis ranged
from a few hours after birth to 2½ months. Age at
surgery ranged from 1 to 6 months (median: 3 months)
(Table 1).
Hypoglycemic convulsion was the most common pre-
senting complaint. All patients had inappropriately
elevated levels of insulin during episodes of hypoglycemia
ranging from 12 to 125 mU/ml. The insulin-to-glucose
ratio was high for all patients, and all patients required
glucose infusion rate greater than 15 mg/kg/min. All
patients had normal growth hormone, cortisol, and
thyroid hormone levels. Lactate, pyruvate, and ammonia
levels were also normal. Urinary organic acid screening
and tandem mass spectrometry screening were negative
for all patients. MRI of the brain was significant for two
patients who later developed epilepsy. Ultrasound
examination of the abdomen was unremarkable. All
patients were started on diazoxide, octreotide, and
glucose infusion. In addition, glucagon was given (as
required) PRN. The medical treatment was considered
a failure when patients, despite undergoing maximum
treatment, had hypoglycemic episodes. All patients
required surgery after failure of medical treatment. Three
patients underwent 95% pancreatectomy, two patients
underwent 90% pancreatectomy, and one patient under-
went 70% pancreatectomy. Two patients (one who
underwent 90% pancreatectomy and another who under-
went 95% pancreatectomy) had repeated hypoglycemic
episodes that required medical treatment after surgery,
which later required a second surgery. Obvious over-
growth of the remaining pancreas was observed during
the second surgery of the patient who underwent 95%
pancreatectomy, which was performed 4 months after the
first surgery.
Three patients developed diabetes: two at 10 years of age,
including one who had 70% pancreatectomy, and one at 1
year of age. None of the patients had exocrine insufficiency
or developmental delay. Two patients developed epilepsy
later (Table 2). There was no mortality. All patients
continue to be followed at the clinic. Histology for all
patients revealed diffuse nesidioblastosis.
Discussion
We have presented the clinical outcome of six patients
with PHHI who underwent surgery after failure of medical
treatment with a mean follow-up of 8.25 years. Most of the
cases are sporadic. However, in our series we had four
patients from the familial group (66.6%) and two from the
sporadic group (33.2%). Insulin-dependent diabetes de-
veloped in three out of six (50%) treated children (two at
the age of 10 years and one at the age of 1 year). Other
investigators have found that diabetes develops in 56% of
children having near-total pancreatectomy [9]. We found
that older age at surgery leads to greater risk of diabetes, in
agreement with previous studies [10]. This finding
relating age at surgery and development of diabetes needs
confirmation with larger case series before they can be
generalized. Two children were hypoglycemic after surgery,
requiring medical treatment, which later required second
surgery. One patient underwent 90% pancreatectomy
during the first surgery and the other underwent 95%
pancreatectomy. Overgrowth of the remaining pancreas
was observed in one patient who underwent 95% resection.
Postpancreatectomy pancreatic regrowth in four infants
with PHHI has also been documented in other stu-
dies [9,11]. Postpancreatectomy regrowth is well docu-
mented in experimental models [12]. The patient who
underwent 70% pancreatectomy (the first case in our
series) was operated upon by a general surgeon who was
covering the service of pediatric surgery at that time. This
might explain the underestimation of the actual percen-
tage of the pancreatectomy in this case, which did well
postoperatively.
All patients were developmentally normal and two
patients (33.3%) were diagnosed with epilepsy after a
Table 1 Patients’ age, birth weight, and age at presentation, diagnosis, and surgery
Familial cases Sporadic cases
1 2 3 4 5 6
Age at last follow-up visit 17 years 8 years 7 years 5 years 12 years 6 months
Age at presentation 5 days First day First day First day 6 days 2 days
Birth weight 3.3 kg 3.8 kg 3.8 kg 3.6 kg 3.5 kg 3.3 kg
Age at diagnosis 75 days First day First day First day 60 days 45 days
Age at surgery 6 months 1 month 1 month 1 month 3 months 3 months
Table 2 Type of surgery and long-term outcomes
Familial cases Sporadic cases
1 2 3 4 5 6
Type of surgery 70% 90% followed by 95% 90% 95% 95% 95% followed by 98%
Hypoglycemia No Following first surgery No No No Following first surgery
Age at development of diabetes 10 years None None 1 year 10 years None
Exocrine insufficiency No No No No No No
Neurological abnormality Epilepsy Epilepsy None None None None
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few years as compared with 64% of patients with
developmental delay in another series [13], possibly
associated with delayed treatment.
In our cases, age at diagnosis ranged from a few hours
after birth to 2½ months (median age, few hours). This is
because most of our patients were from the same family
and had been admitted soon after birth to the Neonatal
Intensive Care Unit for workup.
Conclusion
The earlier the age at diagnosis, the better the
neurological outcome. Delayed surgery might be asso-
ciated with higher risk of development of diabetes.
Pancreatectomy 90–95% is the treatment of choice for
PHHI not responsive to medical treatment.
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